Mutation in the Two-Component System Regulator YycH Leads to Daptomycin Tolerance in Methicillin-Resistant Staphylococcus aureus upon Evolution with a Population Bottleneck
- PMID: 35913149
- PMCID: PMC9431245
- DOI: 10.1128/spectrum.01687-22
Mutation in the Two-Component System Regulator YycH Leads to Daptomycin Tolerance in Methicillin-Resistant Staphylococcus aureus upon Evolution with a Population Bottleneck
Abstract
Adaptive laboratory evolution (ALE) is a useful tool to study the evolution of antibiotic tolerance in bacterial populations under diverse environmental conditions. The role of population bottlenecks in the evolution of tolerance has been investigated in Escherichia coli, but not in a more clinically relevant pathogen, methicillin-resistant Staphylococcus aureus (MRSA). In this study, we used ALE to evolve MRSA under repetitive daptomycin treatment and incorporated population bottlenecks following antibiotic exposure. We observed that the populations finally attained a tolerance mutation in the yycH gene after 2 weeks of evolution with population bottlenecks, and additional mutations in yycI and several other genes further increased the tolerance level. The tolerant populations also became resistant to another glycopeptide antibiotic, vancomycin. Through proteomics, we showed that yycH and yycI mutations led to the loss of function of the proteins and downregulated the WalKR two-component system and the downstream players, including the autolysin Atl and amidase Sle1, which are important for cell wall metabolism. Overall, our study offers new insights into the evolution of daptomycin tolerance under population bottlenecking conditions, which are commonly faced by pathogens during infection; the study also identified new mutations conferring daptomycin tolerance and revealed the proteome alterations in the evolved tolerant populations. IMPORTANCE Although population bottlenecks are known to influence the evolutionary dynamics of microbial populations, how such bottlenecks affect the evolution of tolerance to antibiotics in a clinically relevant methicillin-resistant S. aureus (MRSA) pathogen are still unclear. Here, we performed in vitro evolution of MRSA under cyclic daptomycin treatment and applied population bottlenecks following the treatment. We showed that under these experimental conditions, MRSA populations finally attained mutations in yycH, yycI, and several other genes that led to daptomycin tolerance. The discovered yycH and yycI mutations caused early termination of the genes and loss of function of the proteins, and they subsequently downregulated the expression of proteins controlled by the WalKR two-component system, such as Atl and Sle1. In addition, we compared our proteomics data with multiple studies on distinct daptomycin-tolerant MRSA mutants to identify proteins with a consistent expression pattern that could serve as biological markers for daptomycin tolerance in MRSA.
Keywords: MRSA; WalKR; YycH; YycI; daptomycin; evolution; population bottleneck; tolerance; two-component system.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution.mSphere. 2021 Oct 27;6(5):e0069221. doi: 10.1128/mSphere.00692-21. Epub 2021 Sep 29. mSphere. 2021. PMID: 34585959 Free PMC article.
-
Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.J Antimicrob Chemother. 2015 Nov;70(11):2965-72. doi: 10.1093/jac/dkv225. Epub 2015 Jul 27. J Antimicrob Chemother. 2015. PMID: 26216581
-
In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.J Infect Dis. 2020 Mar 16;221(Suppl 2):S243-S252. doi: 10.1093/infdis/jiz571. J Infect Dis. 2020. PMID: 32176794
-
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.Infect Dis Clin North Am. 2020 Dec;34(4):849-861. doi: 10.1016/j.idc.2020.04.003. Epub 2020 Sep 30. Infect Dis Clin North Am. 2020. PMID: 33011050 Review.
-
MprF-mediated daptomycin resistance.Int J Med Microbiol. 2019 Jul;309(5):359-363. doi: 10.1016/j.ijmm.2019.05.010. Epub 2019 Jun 4. Int J Med Microbiol. 2019. PMID: 31182276 Review.
Cited by
-
Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance.Antibiotics (Basel). 2023 May 18;12(5):928. doi: 10.3390/antibiotics12050928. Antibiotics (Basel). 2023. PMID: 37237831 Free PMC article.
-
Characterisation of in vitro resistance selection against second-/last-line antibiotics in methicillin-resistant Staphylococcus aureus ATCC 43300 strain.JAC Antimicrob Resist. 2025 Jun 23;7(3):dlaf108. doi: 10.1093/jacamr/dlaf108. eCollection 2025 Jun. JAC Antimicrob Resist. 2025. PMID: 40583992 Free PMC article.
-
Proteomic study of evolved Pseudomonas aeruginosa strains grown in Staphylococcus aureus- and Klebsiella pneumoniae-conditioned media.mSystems. 2025 Jul 22;10(7):e0011125. doi: 10.1128/msystems.00111-25. Epub 2025 Jun 3. mSystems. 2025. PMID: 40459270 Free PMC article.
-
Staphylococcus aureus nt5 gene mutation through CRISPR RNA-guided base editing weakens bacterial virulence and immune evasion.Virulence. 2025 Dec;16(1):2451163. doi: 10.1080/21505594.2025.2451163. Epub 2025 Jan 22. Virulence. 2025. PMID: 39843407 Free PMC article.
-
Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus.bioRxiv [Preprint]. 2025 Apr 5:2023.11.30.569373. doi: 10.1101/2023.11.30.569373. bioRxiv. 2025. PMID: 38077036 Free PMC article. Preprint.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases